Repare Therapeutics Inc.
RPTX
Price:
$2.81
Market Cap:
$119.46M
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that focuses on genomic instability, including DNA damage repair. Its lead product candidate is RP-3500, an oral small molecule inhibitor for the treatment of solid tumors with specific DNA damage repair-related genomic alterations. It is also developing RP-6306, which is under Phase I clinical trial for tumors with genetic alterations characterized by CCNE1 ...[Read more]
Industry
Biotechnology
IPO Date
2020-06-19
Stock Exchange
NASDAQ
Ticker
RPTX
PE Ratio
[-1.41]
ROE
[-40.87%]
Current Ratio
[6.45]
Dividend Yield
[0%]
Enterprise Value
[41.48M]
Dividend History
The ROE as of November 2024 (TTM) for Repare Therapeutics Inc. (RPTX) is -40.87%
According to Repare Therapeutics Inc.’s latest financial reports and current stock price. The company's current ROE is -40.87%. This represents a change of 269.16% compared to the average of -11.07% of the last 4 quarters.
Repare Therapeutics Inc. (RPTX) Historical ROE (quarterly & annually)
How has RPTX ROE performed in the past?
The mean historical ROE of Repare Therapeutics Inc. over the last ten years is 1.79%. The current -40.87% ROE has changed -2388.36% with respect to the historical average. Over the past ten years (40 quarters), RPTX's ROE was at its highest in in the September 2022 quarter at 24.68%. The ROE was at its lowest in in the March 2019 quarter at -50.99%.
Average
1.79%
Median
-10.39%
Minimum
-44.23%
Maximum
63.81%
Repare Therapeutics Inc. (RPTX) ROE by Quarter and Year
Discovering the peaks and valleys of Repare Therapeutics Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual ROE = 63.81%
Minimum Annual Increase = -131.56%
Minimum Annual ROE = -44.23%
| Year | ROE | Change |
|---|---|---|
| 2023 | -44.23% | 325.59% |
| 2022 | -10.39% | -71.96% |
| 2021 | -37.07% | 99.03% |
| 2020 | -18.62% | -131.56% |
| 2019 | 59.00% | -7.54% |
| 2018 | 63.81% | Infinity% |
Repare Therapeutics Inc. (RPTX) Average ROE
How has RPTX ROE performed in the past?
The current ROE of Repare Therapeutics Inc. (RPTX) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-30.56%
5-year avg
-10.26%
10-year avg
1.79%
Repare Therapeutics Inc. (RPTX) ROE vs. Peers
How is RPTX’s ROE compared to its peers?
Repare Therapeutics Inc.’s ROE is greater than Accolade, Inc. (-18.43%), greater than Nurix Therapeutics, Inc. (-63.39%), greater than 908 Devices Inc. (-39.48%), greater than Relay Therapeutics, Inc. (-45.75%), greater than Fusion Pharmaceuticals Inc. (-48.74%),
| Company | ROE | Market cap |
|---|---|---|
| -18.43% | $297.99M | |
| -63.39% | $1.56B | |
| -39.48% | $89.15M | |
| -45.75% | $795.07M | |
| -48.74% | $1.83B |
Build a custom stock screener for Repare Therapeutics Inc. (RPTX) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Repare Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Repare Therapeutics Inc. (RPTX) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Repare Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Repare Therapeutics Inc.'s ROE?
How is the ROE calculated for Repare Therapeutics Inc. (RPTX)?
What is the highest ROE for Repare Therapeutics Inc. (RPTX)?
What is the 3-year average ROE for Repare Therapeutics Inc. (RPTX)?
What is the 5-year average ROE for Repare Therapeutics Inc. (RPTX)?
How does the current ROE for Repare Therapeutics Inc. (RPTX) compare to its historical average?